UFP Technologies (UFPT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 4, 2025, will be held virtually with voting on key proposals including director elections, executive compensation, and auditor ratification.
Seven directors are standing for election to serve until the 2026 annual meeting.
Proposals include advisory votes on executive compensation and its frequency, and ratification of Grant Thornton LLP as the independent auditor.
Voting matters and shareholder proposals
Shareholders will vote to elect seven directors, approve executive compensation (say-on-pay), determine the frequency of future say-on-pay votes, and ratify the appointment of Grant Thornton LLP as auditor.
Board recommends voting for all director nominees, for executive compensation, for a triennial say-on-pay vote, and for auditor ratification.
Shareholder proposals and director nominations for the 2026 meeting must be submitted by specified deadlines and follow detailed procedures.
Board of directors and corporate governance
Board consists of seven members, six of whom are independent under Nasdaq standards.
Board committees include Audit, Compensation, and Nominating, all composed of independent directors.
Lead Independent Director role established to enhance oversight, currently held by Mr. Croteau.
Board diversity is considered broadly, including skills, experience, gender, and race.
Directors attended at least 75% of meetings in 2024, and all attended the 2024 annual meeting.
Latest events from UFP Technologies
- Exclusive materials, strategic acquisitions, and strong contracts fuel high-margin growth.UFPT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - MedTech-focused manufacturer targets 12–18% revenue growth and 17–20% margins via innovation and acquisitions.UFPT
Investor presentation3 Mar 2026 - 2025 sales up 19.5% to $602.8M, with record net income and strong medical market growth.UFPT
Q4 202525 Feb 2026 - Exclusive materials, strategic acquisitions, and medtech focus drive robust growth and margins.UFPT
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Executing on acquisitions and expanding in med tech, with strong customer partnerships and margin gains.UFPT
CJS Securities Annual New Ideas For the New Year Conference 202410 Jan 2026 - Exclusive materials, custom processes, and acquisitions fuel rapid Medtech growth and resilience.UFPT
Piper Sandler 37th Annual Healthcare Conference3 Dec 2025 - Record Q1 sales up 41% to $148.1M, led by medical growth and strategic expansion.UFPT
Q1 202524 Nov 2025 - Strong growth in medical device outsourcing, driven by innovation, acquisitions, and client focus.UFPT
16th Annual Midwest Ideas Conference23 Nov 2025 - Q2 sales up 37% to $151.2M, MedTech up 46%, with margin rebound expected in Q4.UFPT
Q2 202523 Nov 2025